1. Research
  2. Growth Control and Cancer Metastasis
  3. Growth Control and Cancer Metastasis publications

Growth Control and Cancer Metastasis publications

Regulation of death receptor signaling by the autophagy protein TP53INP2
Ivanova S, Polajnar M, Narbona-Perez AJ, Hernandez-Alvarez MI, Frager P, Slobodnyuk K, Plana N, Nebreda AR, Palacin M, Gomis RR, Behrends C and Zorzano A.
Embo J (2019)
Benefits and risks of adjuvant treatment with zoledronic acid in stage II/III breast cancer. 10 years follow-up of the AZURE randomized clinical trial (BIG 01/04)
Coleman RE, Collinson M, Gregory W, Marshall H, Bell R, Dodwell D, Keane M, Gil M, Barrett-Lee P, Ritchie D, Bowman A, Liversedge V, De Boer RH, Passos-Coelho JL, O'Reilly S, Bertelli G, Joffe J, Brown JE, Wilson C, Tercero JC, Jean-Mairet J, Gomis R and Cameron D.
J Bone Oncol, 13 123-135 (2018)
CANCERTOOL: A Visualization and Representation Interface to Exploit Cancer Datasets
Cortazar AR, Torrano V, Martín-Martín N, Caro-Maldonado A, Camacho L, Hermanova I, Guruceaga E, Lorenzo-Martín LF, Caloto R, Gomis RR, Apaolaza I, Quesada V, Trka J, Gomez-Muñoz A, Vincent S, Bustelo XR, Planes FJ, Aransay AM and Carracedo A.
Cancer Res, 78 (21), 6320-6328 (2018)
Loxl2 is dispensable for dermal development, homeostasis and tumour stroma formation
Kober KI, Cano A, Géraud C, Sipilä K, Mobasseri SA, Philippeos C, Pisco AO, Stannard A, Martin A, Salvador F, Santos V, Boutros M, Rognoni E and Watt FM.
PLoS One, 13 (6), e0199679 (2018)
Organ-specific metastases
Urosevic, J., Gomis, R.
Nature Biomedical Engineering (2018)
CLK2 blockade modulates alternative splicing compromising MYC-driven breast tumors
Salvador F and Gomis RR.
EMBO Mol Med (2018)
Clinical implications of the non-luminal intrinsic subtypes in hormone receptor-positive breast cancer
Cejalvo JM, Pascual T, Fernández-Martínez A, Brasó-Maristany F, Gomis RR, Perou CM, Muñoz M, Prat A.
Cancer Treat Rev (2018)
Paraspeckle factor turns TGF-β1 pro-metastatic
Salvador F and Gomis RR.
Nat Cell Biol, 20 (4), 367-369 (2018)
MSK1 regulates luminal cell differentiation and metastatic dormancy in ER+ breast cancer
Gawrzak S, Rinaldi L, Gregorio S, Arenas EJ, Salvador F, Urosevic J, Figueras-Puig C, Rojo F, Del Barco Barrantes I, Cejalvo JM, Palafox M, Guiu M, Berenguer-Llergo A, Symeonidi A, Bellmunt A, Kalafatovic D, Arnal-Estapé A, Fernández E, Müllauer B, Groeneveld R, Slobodnyuk K, Stephan-Otto Attolini C, Saura C, Arribas J, Cortes J, Rovira A, Muñoz M, Lluch A, Serra V, Albanell J, Prat A, Nebreda AR, Benitah SA and Gomis RR.
Nat Cell Biol, 20 (2), 211-221 (2018)
Regulation of Mammary Luminal Cell Fate and Tumorigenesis by p38α
Del Barco Barrantes I, Stephan-Otto Attolini C, Slobodnyuk K, Igea A, Gregorio S, Gawrzak S, Gomis RR and Nebreda AR.
Stem Cell Reports (2017)

* shared senior authorship